something on the horizon?, page-26

I, in principle, agree but I do see our pain patch development on the heels of partnering activities and therefore closely connected to our partners.

OBJ management can not, in its wildest dreams, fathom to develop something like this alone.
Either a successful partnering program provides the needed cash to initiate the pain patch development or OBJ needs to partner for it directly as hinted in the latest ann.

Either way, OBJ is in no position to tackle a full development alone and I doubt the Glyn has lost his senses.


With the FMCG not reporting back for over a year now ( I suspect an analgesic OTC development with them ), I would assume that OBJ management had that particular program in mind when making such bold statements of an inhouse developed patch program.

This will need to be verified by announcements in the future and is at the moment my personal opinion.